Complex PTSD Life Expectancy: What the Research Shows

By Katlyne Brutus, MSN, FNP-C, PMHNP-BC | Clearview Behavioral Health and Wellness Services

Short answer: No study has measured complex PTSD life expectancy directly. Complex PTSD (CPTSD) only became an official diagnosis in the World Health Organization’s ICD-11, and long-term mortality research has not caught up yet. What we do have are large studies of PTSD, of adverse childhood experiences, and of chronic stress biology. Those studies link trauma-related distress to higher rates of early death, heart disease, type 2 diabetes, autoimmune disease and suicide. That is an association, not a sentence. Much of the extra risk runs through things that can change: untreated symptoms, depression, sleep, smoking, weight, isolation and missed medical care. Evidence from veterans suggests that when PTSD symptoms improve meaningfully, diabetes risk drops and quitting smoking becomes more likely.

Key takeaways • There is no published life expectancy figure for complex PTSD; any number you see online was borrowed from another population. • A 2023 meta-analysis of 30 studies found PTSD was associated with a higher risk of death, but the studies varied widely and most involved male veterans. • The often-quoted “20 years earlier” figure comes from people with six or more adverse childhood experiences who died during follow-up. It was never a CPTSD statistic or a lifespan prediction. • Suicide and accidents account for a large share of excess deaths in recent data. • Heart, metabolic and immune risks are partly explained by modifiable factors such as smoking, body weight and blood pressure. • Meaningful PTSD improvement has been linked to lower type 2 diabetes risk and higher odds of quitting smoking.

Does complex PTSD shorten life expectancy?

No study has shown that a CPTSD diagnosis cuts a predictable number of years from a life. The research points to higher average risk, concentrated in suicide, accidents, cardiovascular disease and metabolic disease, and much of it is treatable or preventable.

When patients ask me this, they have usually read a frightening number online or noticed their body wearing down. What follows sticks to what the studies measured, who was in them, and where the evidence runs out.

What is complex PTSD?

Complex PTSD is a trauma-related condition defined in the ICD-11 under code 6B41, complex post traumatic stress disorder. The WHO describes it as developing after extremely threatening events, most commonly prolonged or repeated ones that are hard or impossible to escape, such as repeated childhood abuse, prolonged domestic violence or torture. A 2021 review of how the diagnosis was developed, by Maercker in Borderline Personality Disorder and Emotion Dysregulation, summarizes the same structure: core PTSD symptoms plus three groups of affective, self-concept and relationship changes.

To meet criteria, a person must have all the core PTSD symptoms (re-experiencing, avoidance and a persistent sense of current threat) plus three “disturbances in self-organization”:

• Affect dysregulation: emotional reactions that are intense, hard to settle, or shut down into numbness and dissociation.
• Negative self-concept: a lasting belief of being worthless, defeated or diminished, with shame or guilt tied to the trauma.
• Relationship difficulties: trouble staying close to people or sustaining relationships.

Is complex PTSD in the DSM-5-TR?

No. The American Psychiatric Association’s DSM-5-TR, which US clinicians use for diagnosis, does not list complex PTSD separately. As the VA National Center for PTSD explains, DSM-5 folded some complex features (self-blame, persistent negative mood, self-destructive behavior) into PTSD itself and added a dissociative subtype. In practice, many Americans with CPTSD symptoms carry a PTSD diagnosis in their chart.

How common is it, and how is it measured?

A population-based study in the Journal of Traumatic Stress by Cloitre and colleagues (2019) estimated that 3.8% of US adults met ICD-11 criteria for CPTSD and 3.4% for PTSD. Cumulative childhood trauma was more strongly tied to CPTSD than to PTSD. Researchers and clinicians usually screen with the 12-item International Trauma Questionnaire (ITQ), a self-report measure built to match ICD-11 criteria. A full clinical evaluation still confirms the diagnosis.

Why there is no complex PTSD life expectancy figure yet

Measuring life expectancy requires following a large group of people for many years and counting deaths. ICD-11 is a recent classification, and no cohort defined by ICD-11 CPTSD has been followed long enough to report mortality.

So the honest approach is to look at three overlapping bodies of evidence:

1. PTSD mortality studies, the closest proxy, since everyone with CPTSD meets PTSD criteria.
2. Adverse childhood experience (ACE) research, because chronic childhood trauma is a common path into CPTSD.
3. Chronic stress biology, including inflammation and cellular aging.

None can be converted into “years lost” for a person with CPTSD.

What research shows about PTSD and early death

PTSD and all-cause mortality

The broadest summary is a 2023 systematic review and meta-analysis in BMC Psychiatry by Nilaweera and colleagues. Across 30 studies including more than 2.1 million people with PTSD, PTSD was associated with a higher risk of death: 32% higher in the 18 studies that tracked time to death (hazard ratio 1.32). The authors flagged very high heterogeneity and noted that most samples were male-dominated veteran populations.

In the Nurses’ Health Study II, Roberts and colleagues (2020, JAMA Network Open) followed 51,602 women in midlife from 2008 to 2017. Women with high PTSD symptoms and probable depression had nearly four times the risk of death of women with neither trauma exposure nor depression (hazard ratio 3.80), and more than three times the risk after adjusting for health factors (3.11). Even subclinical PTSD symptoms without depression carried a modestly higher risk (1.43). Excess deaths came from cardiovascular disease, diabetes, unintentional injury and suicide. The sample was 97% White.

Suicide and accidents drive much of the excess

A 2026 nationwide Taiwanese cohort in Epidemiology and Psychiatric Sciences by Hsu and colleagues compared 28,777 people with newly diagnosed PTSD with 115,108 matched people, plus their siblings. Over a mean follow-up of 8 years, PTSD was linked to roughly 30% higher all-cause mortality. The excess was driven by unnatural deaths: suicide risk was about 10 times higher, and accidental deaths were also raised. Natural-cause deaths did not show a consistent increase in that population.

Clinically, that tells me safety planning, treatment of co-occurring depression, and attention to substance use and risk-taking matter as much for longevity as blood pressure checks.

If you are having thoughts of suicide, call or text 988 to reach the 988 Suicide and Crisis Lifeline, available 24 hours a day.

Childhood adversity and premature death

The landmark ACE Study by Felitti and colleagues (1998) surveyed 9,508 adult patients of a large California health maintenance organization. People with four or more categories of childhood adversity, compared with none, had 4- to 12-fold higher risk of alcoholism, drug use, depression and suicide attempts. The number of adversity categories showed a graded relationship with ischemic heart disease, cancer, chronic lung disease, skeletal fractures and liver disease.

The figure most CPTSD articles repeat comes from a follow-up by Brown and colleagues (2009). Among 17,337 ACE Study adults followed to the end of 2006, 1,539 died. Among those who died, people with six or more ACEs died at an average age of 60.6, compared with 79.1 for those with no ACEs. After adjustment, people with six or more ACEs were 2.4 times more likely to die at age 65 or younger.

Read that carefully, because it is widely misquoted:

• It describes average age at death among people who died during follow-up. Life expectancy for everyone with a high ACE score was never calculated.
• It measured childhood adversity, not CPTSD. Many people with high ACE scores never develop CPTSD, and some people with CPTSD have low ACE scores.
• The authors found no clear graded increase in risk across ACE categories, and documented health and social problems only partly explained the risk.

The study remains one of the strongest pieces of evidence that childhood adversity matters for adult health. What it cannot support is the claim that CPTSD takes 20 years off a life.

Trauma, PTSD and physical illness

Heart disease and stroke

A meta-analysis in the American Heart Journal by Edmondson and colleagues (2013) pooled six prospective studies (402,274 participants). PTSD was associated with a 55% higher risk of incident coronary heart disease, and a 27% higher risk after adjusting for depression (hazard ratio 1.27).

In women, Sumner and colleagues (2015, Circulation) followed 49,978 Nurses’ Health Study II participants for 20 years. Four or more PTSD symptoms were associated with a 60% higher risk of heart attack or stroke compared with no trauma exposure. Adult health behaviors and medical risk factors accounted for 47% of that association.

Type 2 diabetes

In the same cohort, Roberts and colleagues (2015, JAMA Psychiatry) found a dose-response pattern over 22 years: women with six or seven PTSD symptoms had nearly double the risk of type 2 diabetes (hazard ratio 1.8). Higher body mass index and antidepressant use associated with PTSD accounted for nearly half of the added risk. It is one reason I check weight and metabolic labs when I prescribe.

Autoimmune disease

A Swedish registry study in JAMA by Song and colleagues (2018) compared 106,464 people with stress-related disorders with over a million matched controls and with their siblings. PTSD was associated with a 46% higher risk of any autoimmune disease and more than double the risk of having three or more (hazard ratio 2.29). Persistent SSRI use in the first year after diagnosis was associated with a smaller increase in risk, an observational hint that treatment may help.

Accelerated biological aging

This is the area where online claims run furthest ahead of the data.

• A 2018 meta-analysis in Psychoneuroendocrinology by Wolf and colleagues found that childhood trauma and lifetime PTSD severity had significant but small associations with accelerated DNA methylation age. A PTSD diagnosis by itself was not associated.
• Katrinli and colleagues (2020, Neuropsychopharmacology) studied 854 trauma-exposed civilians and found lifetime trauma burden, current PTSD and lifetime PTSD were associated with acceleration of GrimAge, an epigenetic estimate linked to mortality risk.
• A 2017 meta-analysis in the Journal of Affective Disorders by Li and colleagues linked PTSD with shorter telomeres across five studies, with very high heterogeneity.

Epigenetic clocks and telomere length are research tools that describe group averages. No laboratory currently offers a test that can tell an individual with CPTSD how long they will live.

Dementia in later life

A 2020 meta-analysis in the British Journal of Psychiatry by Günak and colleagues pooled eight studies covering more than 1.6 million people and found PTSD was associated with a higher risk of all-cause dementia, in veterans and in the general population. Most included studies were retrospective, heterogeneity was high, and the journal later published an erratum, so this signal still needs prospective confirmation.

Is CPTSD riskier than PTSD for physical health?

We do not know yet. One cross-sectional study of general population samples in Ireland and the UK by Ho and colleagues (2021) found that PTSD symptoms and the self-organization symptoms of CPTSD together accounted for the link between childhood abuse and later somatic complaints, while PTSD symptoms alone accounted for the link with cardiovascular disease load. Because it captured one point in time, it cannot show cause and effect, and no mortality study has compared CPTSD with PTSD.

Evidence at a glance

Health outcome	What studies found	Strength and limits of evidence	Source
All-cause mortality	PTSD linked to about 32% higher risk of death across 18 time-to-death studies	30 studies; very high heterogeneity; mostly male veterans	Nilaweera et al., BMC Psychiatry, 2023
Mortality in midlife women	High PTSD symptoms plus probable depression: about 3 to 4 times the risk of death	Prospective cohort; mostly White nurses; self-reported symptoms	Roberts et al., JAMA Network Open, 2020
Suicide and accidents	All-cause mortality roughly 30% higher; suicide about 10 times higher; no consistent rise in natural-cause deaths	National registry with sibling comparison; Taiwanese population	Hsu et al., Epidemiology and Psychiatric Sciences, 2026
Premature death after childhood adversity	Six or more ACEs: 2.4 times more likely to die by 65; decedents died about 20 years younger on average	Prospective cohort; measured ACE count only; wide confidence intervals; no graded trend	Brown et al., Am J Prev Med, 2009
Coronary heart disease	27% higher risk after adjusting for depression	Meta-analysis of six prospective studies; observational	Edmondson et al., Am Heart J, 2013
Heart attack and stroke in women	60% higher risk with 4 or more PTSD symptoms; behaviors and risk factors explained 47%	20-year cohort; women only	Sumner et al., Circulation, 2015
Type 2 diabetes	Nearly double the risk with 6 or 7 PTSD symptoms; BMI and antidepressant use explained about half	22-year cohort; women only	Roberts et al., JAMA Psychiatry, 2015
Autoimmune disease	PTSD linked to 46% higher risk; SSRI use associated with smaller increase	National registry with sibling controls; Swedish population; observational	Song et al., JAMA, 2018
Biological aging markers	Small associations with epigenetic age acceleration and shorter telomeres	Surrogate markers with no deaths counted; mixed and heterogeneous results	Wolf et al., 2018; Katrinli et al., 2020; Li et al., 2017
CPTSD symptoms and physical health	CPTSD symptom clusters accounted for links between childhood trauma and somatic complaints	Cross-sectional; one of very few CPTSD-specific studies	Ho et al., J Psychosom Res, 2021

How chronic trauma stress affects the body

No single mechanism explains these findings; in practice I see several working together.

Allostatic load and stress hormones. Stress systems, including the hypothalamic-pituitary-adrenal (HPA) axis that regulates cortisol, are built for short bursts. Allostatic load is the term for the cumulative wear when the threat response stays switched on for years.

Inflammation. A meta-analysis in Lancet Psychiatry by Passos and colleagues (2015) found higher levels of interleukin 6, interleukin 1 beta and interferon gamma in people with PTSD than in healthy controls.

Sleep disruption. Nightmares and insomnia are common in CPTSD, and in my evaluations poor sleep is one of the first things patients describe. It also makes mood, appetite and blood pressure harder to manage.

Health behaviors. Smoking, heavy drinking, overeating and inactivity are often ways of managing unbearable states. In the Nurses’ Health Study II data above, behaviors and medical risk factors explained 47% of the link between high PTSD symptoms and heart attack or stroke.

Healthcare avoidance. Being touched, lying down or losing control in a medical setting can be triggering. Patients regularly tell me they have skipped screenings or dental care for years because of it.

Social isolation. The relationship difficulties at the core of CPTSD can mean fewer people notice when something is wrong, and less support during illness.

Can treatment change the outlook?

Yes, within limits. No trial has shown that treating CPTSD lengthens life. What we have are studies showing that when PTSD improves, some physical risks move in the right direction.

• Diabetes: In 1,598 veterans in PTSD specialty care, Scherrer and colleagues (2019, JAMA Psychiatry) found that those with a clinically meaningful drop in PTSD Checklist scores (20 points or more) developed type 2 diabetes about half as often over follow-up (hazard ratio 0.51).
• Smoking: Veterans with large PTSD improvement were more likely to quit smoking within two years (hazard ratio 1.57) in a study by Salas and colleagues (2022).
• Blood pressure: The same research group found only limited evidence that PTSD improvement lowered hypertension risk and no link with cholesterol or weight loss, according to Scherrer and colleagues (2020, Health Psychology). Mental health treatment does not replace medical care.

All three are observational studies in veterans, more than 80% of them men, so they cannot prove that treatment caused the change. In the diabetes study, cumulative incidence was 2.6% with meaningful improvement and 5.9% without it.

Trauma-focused therapy for complex PTSD

The VA National Center for PTSD lists three trauma-focused therapies with the strongest research support: cognitive processing therapy (CPT), prolonged exposure (PE), and eye movement desensitization and reprocessing (EMDR). Written exposure therapy is a shorter, supported option. These therapies are delivered in outpatient mental health treatment, and the VA notes that most last about three months.

For CPTSD specifically, a 2019 meta-analysis of 51 randomized trials in Psychological Medicine by Karatzias and colleagues found that cognitive behavioral therapies, exposure and EMDR improved core PTSD symptoms and had moderate to large effects on negative self-concept and relationship problems. Childhood-onset trauma was associated with poorer outcomes, which is why many clinicians use a flexible or phase-based approach.

Phase-based care starts with stabilization and skills, then moves to trauma processing. The best-studied example is STAIR (Skills Training in Affective and Interpersonal Regulation). In a trial of 104 women with PTSD related to childhood abuse, Cloitre and colleagues (2010) found that STAIR followed by exposure produced more sustained full PTSD remission: 27% versus 13% for the exposure-only comparison, with fewer cases of symptom worsening.

Where medication fits

There is no medication approved specifically for complex PTSD. The VA National Center for PTSD recommends three medications for PTSD symptoms: sertraline (Zoloft), paroxetine (Paxil) and venlafaxine (Effexor). In my practice, medication is most often used to treat what travels with CPTSD: major depressive disorder, anxiety and sleep problems.

Good psychiatric medication management also means watching weight, blood sugar and blood pressure, because some psychiatric medications can affect them. Any change in a medication or dose should be decided with your prescriber.

Practical steps that protect your health

None of these require you to have finished processing your trauma first.

Step	Why it matters for CPTSD
See a primary care clinician yearly; ask for blood pressure, lipid and A1c checks	Cardiometabolic risk is where much of the excess sits, and it is often silent
Tell your clinician what makes appointments hard	Small accommodations (explaining exams first, a chaperone, sitting up) reduce avoidance
Make sleep a treatment target of its own	Nightmares and insomnia respond to specific treatment and affect heart and metabolic health
Address smoking and alcohol with support	Both raise the risk of early death; veterans with large PTSD improvement quit smoking more often
Move most days, even briefly	Regular activity supports mood, sleep, weight and blood pressure
Keep one or two reliable connections	Isolation raises risk; support helps people stay in care
Have a written crisis plan	Suicide is a leading contributor to excess deaths in PTSD studies

When to get help right away

Seek urgent help if you have thoughts of ending your life, have made a plan, have started acting on self-harm, or are using alcohol or drugs in ways that put you in danger. Also act quickly on chest pain, shortness of breath, sudden weakness or confusion; trauma can make people dismiss physical warning signs as “just anxiety.”

Schedule a non-urgent evaluation if CPTSD symptoms have lasted for months, or if you were treated for PTSD but the shame, emotional swings and relationship struggles were never addressed. Years of low, flat mood that never fully lifts can also be a sign of chronic depression layered on top of trauma, that deserves its own treatment.

If you live in Massachusetts and are unsure where to start, mental health care in Massachusetts can begin with your primary care office, an outpatient psychiatric practice or a therapist, and you do not need a confirmed CPTSD diagnosis to ask for help.

For family members and partners

If someone you love has CPTSD, practical help matters most: offer to go with them to a medical appointment, notice changes in sleep, drinking or withdrawal, and ask directly about suicidal thoughts if you are concerned. Trauma can look different by gender; the symptoms of PTSD in men often show up as anger, numbness or heavy drinking rather than visible distress, which makes them easier to miss.

Frequently asked questions

Can complex PTSD kill you?

Complex PTSD is not fatal in itself. The risk comes from what can accompany it: suicide, accidents, substance use, and long-term heart and metabolic strain. Recent research shows suicide is a large contributor to excess deaths in PTSD, which is why crisis support and treatment matter.

What is the life expectancy of someone with CPTSD?

There is no established figure. No study has followed an ICD-11 CPTSD group long enough to measure it. PTSD studies show higher average mortality risk at the group level, but individual outcomes vary widely and much of the risk is modifiable.

Is the “20 years shorter life” statistic true for CPTSD?

No. That figure comes from Brown and colleagues’ 2009 ACE Study follow-up and describes the average age at death of people with six or more childhood adversities who died during follow-up. The study measured childhood adversity, and it never estimated life expectancy.

Does complex PTSD get worse with age?

It does not inevitably worsen, but untreated symptoms tend to persist, and the physical effects of chronic stress, poor sleep and health habits accumulate over time. Treatment can help at any age, including later in life.

Is complex PTSD the same as borderline personality disorder?

No, although they share features such as emotional intensity and relationship strain. ICD-11 lists personality disorder as an exclusion for CPTSD, and Maercker’s 2021 review reports that the CPTSD diagnosis has shown good discrimination from personality disorder with borderline pattern. A careful evaluation looks at trauma history, symptom pattern and how a person sees themselves.

Can you recover from complex PTSD?

Yes. Trials show that trauma-focused therapies and phase-based approaches such as STAIR reduce PTSD symptoms, and meta-analytic evidence shows gains in self-concept and relationships too. In the STAIR trial, 27% of women in the skills-then-exposure group reached sustained full remission.

Do I need a CPTSD diagnosis to get treatment?

No. In the US, care is usually provided under a DSM-5-TR PTSD diagnosis, and treatment targets the symptoms you actually have, including shame, emotional swings and relationship strain.

Getting care at Clearview Behavioral Health and Wellness Solutions

At Clearview Behavioral Health and Wellness Services, I provide psychiatric evaluation and medication management for adults with trauma-related conditions, including PTSD and trauma care alongside the depression, anxiety and sleep problems that often come with it. We see patients in person in Braintree and Worcester and by secure video anywhere in Massachusetts. Care is coordinated with your therapist and primary care clinician so your physical health is part of the plan. We accept MassHealth and many commercial plans, and you can book an evaluation when you are ready or call 781-236-3645.

Medical disclaimer: This article is for general education and does not replace a personal evaluation, diagnosis or treatment from a qualified clinician. Study findings describe groups of people and cannot predict any individual’s lifespan. Do not start, stop or change any medication without talking to your prescriber. If you are in crisis, call or text 988, or call 911 in an emergency.